Article
18 Jun 2026
The 2026 Pharmaceutical Patent Review
AUTHORS CONTENT
Article
10 May 2026
Australia | Navigating Best Method After NOCO
Article
28 Feb 2026
Lessons from recent interlocutory injunctions in pharmaceutical patent cases
Article
13 Dec 2025
Patents: The Evolving Law Of Support And Sufficiency
Article
20 Sep 2025
Aristocrat Decision Changes Patent Eligibility Of Computer-implemented Inventions
Article
12 Feb 2025
Legal 500 country guide I Patent litigation in Australia
Article
23 Dec 2024
Australia | Five key lessons from the High Court's decision in the Commonwealth damages case
Article
12 Jun 2024
Skinny labelling in the Australian context: an overview
Article
09 May 2024
Infringement of second medical use claims - Federal Court decision adds guidance
Article
17 Apr 2024
The 2023 Pharmaceutical Patent Review
Article
06 Feb 2024
The 2023 IP year in review, and predictions for 2024
Article
21 Sep 2022
What the High Court decision in Aristocrat means for patent owners
Article
07 Apr 2021
Long-running patent dispute relating to Lundbeck antidepressant Lexapro reaches High Court for a third time
Article
06 Nov 2020
The bar has been raised: Prevnar® vaccine case demonstrates the impact of Australian patent law reforms
Article
01 Jun 2020
Switching from biologic to biosimilar: Unique approach in Australia
Article
19 May 2020
TGA transparency reforms (part 2): Early publication of major innovator prescription medicine applications
Article
12 May 2020
Federal Court dismisses first Commonwealth damages claim against an unsuccessful pharmaceutical patentee
Article
09 May 2020
TGA Transparency reforms (part 1): Notification of generic and biosimilar medicines to impact pharmaceutical patent disputes in Australia